The most common side effects of Belviq in non-diabetic patients are headache, dizziness, fatigue, nausea, dry mouth, and constipation, and in diabetic patients are low blood sugar (hypoglycemia), headache, back pain, cough, and fatigue.
What is Belviq? 
The drug, Belviq (lorcaserin), was approved for obese adults who have high blood pressure, high cholesterol or type 2 diabetes, and is to be used in combination with a low-calorie diet and exercise, the FDA said.
“Obesity threatens the overall well-being of patients and is a major public health concern,” Dr. Janet Woodcock, director of the FDA’s Center for Drug Evaluation and Research, said in an agency news release. “The approval of this drug, used responsibly in combination with a healthy diet and lifestyle, provides a treatment option for Americans who are obese or are overweight and have at least one weight-related comorbid condition.”
Where to obtain a prescription for Belviq?
In order to obtain a prescription for the new weight loss medication, Belviq (lorcaserin) or the other new weight loss medication, Qsymia (Phentermine, Topiramate), you first need to be evaluated by a physician familiar with these medications such as a W8MD Medical Weight Loss Center’s Physician.
Does W8MD Offer Belviq and Qsymia to eligible patients at its locations?
Yes. After evaluation by our trained obesity medicine weight loss physician, W8MD Medical Weight Loss Centers locations in New York City, North East Philadelphia, King of Prussia PA locations will be able to discuss with if Belviq or Qsymia will be appropriate for you.
The best news is that W8MD will work your insurance for the physician visits, unlike the many cash only weight loss clinics, so that you may not have to pay out of pocket. All you pay will be your co-pay, if you have any. With most insurances accepted for weight loss physician visits, with 2 new FDA approved weight loss medications, losing weight has never been easier.
Locations for Belviq, Qsymia and other non-surgical weight loss measures
W8MD Centers That Accept Most Insurances
- NYC Insurance Weight Loss Center: 2003, Bath Avenue, Brooklyn, NY, 11214 Ph: 1-718-946-5500
- Philadelphia Insurance Weight Loss Center: 1718, Welsh Rd, Philadelphia, PA, 19115 Ph: 1-215-676-2334
- King Of Prussia Weight Loss Center: 987 Old Eagle School Rd, Wayne, PA, 19087 Ph: 1-800-986-3007
- Specialties: Weight Loss Service, Weight Loss Diet Pills, Sleep Clinic, Sleep Study Clinics, Sleep Apnea Clinic, Medical Weight Loss, Weight Loss Pills, Weight Loss Supplements, Fast Weight Loss Options, weight loss diet, weight loss program, Lose Weight Philadelphia, Weight Loss NYC, New York Weight Loss Clinic, Adipex, Phentermine, Generic Phentermine Topiramate, Brand Name Qsymia, Belviq, Lorcaserin Weight Loss Diet Pills, NYC Weight Loss Service, Philadelphia Weight Loss Pills, 800 calorie VLCD Diet, 1000 Calorie LCD Diet, Cheap Weight Loss Low Calorie Diets.
-
Cities Served: Philadelphia, King Of Prussia, Wayne, Brooklyn, Staten Island, Manhattan, New York, New York City, Queens, Long Island, Bronx, Bensonhurst, Stamford, CT.
-
Counties Served: Chester, Philadelphia, Bucks, Montgomery, Burlington, Kings, Richmond, Queens, Manhattan, Bronx
Fee For Service
-
W8MD at Optimal Health, 111 High Ridge Rd, Stamford, CT 06905. Ph: 203-348-8805 Fax: 203-348-6398. This Center is Fee For Service.
Think W8MD (w’eight’MD) for weight loss!
Also read
- Welcome to W8MD’s Blog on Belviq Lorcaserin weight loss medication (belviq.wordpress.com)
- Cost of Belviq Lorcaserin for weight loss (belviq.wordpress.com)
- Phentermine and Topiramate for weight loss – review by W8MD (phenterminetopiramate.wordpress.com)
- Weight loss medications and supplements (freeweightlossdoctor.wordpress.com)
- FDA Approves Lorcaserin and Qsymia,, First Weight Loss Drugs For Heavy Patients In Over a Decade (medicaldaily.com)
Related articles
- Weight loss medications and supplements (freeweightlossdoctor.wordpress.com)
- FDA Approves Lorcaserin and Qsymia,, First Weight Loss Drugs For Heavy Patients In Over a Decade (medicaldaily.com)
